Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07446400) titled 'A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition:
Healthy Volunteers
Intervention:
Drug: Repinatrabit
Drug: EE/NE
Drug: Metformin
Drug: Rosuvastatin
Drug: Methotrexate
Recruitment Status: Not recruiting
Phase: Phase 1
Date of F...